| Application no. and date | 19163006.0 (espacenet) (Federated) (European Patent Register), 20130618 | | Patent/reg. no. and date | DK/EP 3560500, 20211222 | | Publication date | 20191030 | | Priority no. and date | US 201261661302 P, 20120618, US 201261662265 P, 20120620, US 201213684002, 20121121, WO PCT/US2013/023309, 20130125, US 201313843362, 20130315 | | EP pub. no. and date |
EP 3560500 20191030 | | Effective date | | | Applicant/owner | TherapeuticsMD, Inc., 951 Yamato Road, Suite 220
Boca Raton, FL 33431, US | | Applicant ref. no. | | | Inventor | CACACE, Janice Louise, 8442 6th St N
St Petersburg
FL 33702, US,
PERSICANER, Peter H.R., 17070 Royal Cove Way
Boca Raton
FL 33496, US | | Representative | | | Opponent | | | IPC Class | A61K 31/565 (2006.01) , A61K 31/57 (2006.01) , A61K 45/06 (2006.01) , A61K 47/10 (2017.01) , A61K 47/14 (2017.01) , A61K 9/107 (2006.01) , A61K 9/48 (2006.01) | | Title | PROGESTERONE FORMULATIONS | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
